What is the 13F Pro Quality Score for ICU?

13F Pro ranks SeaStar Medical Holding Corp (ICU) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ICU's current score at https://13fpro.ai/company/ICU (free sign-up required for the full ranking).

Where does 13F Pro source ICU data?

All SeaStar Medical Holding Corp fundamentals and ownership data come directly from SEC EDGAR. SeaStar Medical Holding Corp files with the SEC under CIK 1831868. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ICU in?

SeaStar Medical Holding Corp (ICU) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is ICU research updated on 13F Pro?

ICU's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

SeaStar Medical Holding Corp(ICU)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1831868 ICU stock profile & AI dashboard →

13F Pro Quality Score

29.6/100

Rank #2,526 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why ICU Scores 30/100

exact factor attribution · 2026-09-11

ICU's composite is driven by revenue growth and earnings growth, held back by scale and free cash flow. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Revenue growth

+9.8 pts

99th pct

Earnings growth

+1.9 pts

88th pct

Institutional flow

-1.1 pts

29th pct

Shareholder dilution

-2.1 pts

8th pct

Earnings quality

-3.9 pts

11th pct

Capital efficiency

-4.8 pts

2th pct

Profitability

-6.6 pts

6th pct

Free cash flow

-6.8 pts

5th pct

Scale

-7.0 pts

3th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

ICU Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for SeaStar Medical Holding Corp (ICU), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ICU at 29.6/100 on a 32-signal composite quality model, placing it at rank #2,526 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), SeaStar Medical Holding Corp reports quarterly revenue of $615.0K, net income of $-3.7M. Top institutional holders of ICU by reported 13-F value include GEODE CAPITAL MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, UBS Group AG, based on the most recent SEC filings. ICU trades on the Nasdaq exchange and files with the SEC under CIK 1831868. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ICU daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for SeaStar Medical Holding Corp directly from SEC EDGAR. SeaStar Medical Holding Corp's 13F Pro composite quality score has ranged between 25 and 30 since 2026, currently 29.6 — an improving long-term trajectory across 8 quarterly and live scoring snapshots.

Revenue

Q2 2026

$615.0K

Net Income

Q2 2026

$-3.7M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+814.1% YoY

$1.2MFY 2025

FY22 —FY23 $0.00FY24 $135.0KFY25 $1.2M

Net Income

+51.1% YoY

$-12.2MFY 2025

FY22 $-12.2MFY23 $-26.2MFY24 $-24.8MFY25 $-12.2M

Operating Income

+31.8% YoY

$-12.2MFY 2025

FY22 $-11.6MFY23 $-14.2MFY24 $-17.8MFY25 $-12.2M

EPS (Diluted)

—FY 2025

FY22 $-1.48FY23 $-30.26FY24 $-6.63FY25 —

Total Assets

+204.0% YoY

$14.2MFY 2025

FY22 $4.8MFY23 $3.5MFY24 $4.7MFY25 $14.2M

Total Debt

—FY 2025

FY22 $8.8MFY23 $4.9MFY24 $574.0KFY25 —

Op. Cash Flow

+15.0% YoY

$-13.6MFY 2025

FY22 $-7.8MFY23 $-10.3MFY24 $-16.0MFY25 $-13.6M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$1.2M +814.1%	$135.0K	$0.00	—	—	—
Net Income	$-12.2M +51.1%	$-24.8M +5.3%	$-26.2M -115.2%	$-12.2M -165.2%	$-4.6M	—
Operating Income	$-12.2M +31.8%	$-17.8M -25.6%	$-14.2M -22.4%	$-11.6M -160.9%	$-4.4M	—
EPS (Diluted)	—	$-6.63 +78.1%	$-30.26 -1944.6%	$-1.48 -134.9%	$-0.63	—
Total Assets	$14.2M +204.0%	$4.7M +32.6%	$3.5M -26.3%	$4.8M -95.5%	$105.9M +39250.4%	$269.2K
Total Debt	—	$574.0K -88.4%	$4.9M -44.1%	$8.8M	—	—
Operating Cash Flow	$-13.6M +15.0%	$-16.0M -55.6%	$-10.3M -32.0%	$-7.8M -52.4%	$-5.1M	—

Get alerted when ICU's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for SeaStar Medical Holding Corp including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ICU

GEODE CAPITAL MANAGEMENT, LLC
$182.0K49,593 sh
VANGUARD CAPITAL MANAGEMENT LLC
$121.4K33,091 sh
UBS Group AG
$115.2K31,398 sh
VANGUARD FIDUCIARY TRUST CO
$50.3K13,692 sh
JANE STREET GROUP, LLC
$46.4K12,634 sh
NORTHERN TRUST CORP
$38.2K10,402 sh
PNC FINANCIAL SERVICES GROUP, INC.
$18.1K4,943 sh
Tower Research Capital LLC (TRC)
$5.0K1,356 sh
BlackRock, Inc.
$3.4K913 sh
OSAIC HOLDINGS, INC.
$714.00195 sh

Fund	Value	Shares
GEODE CAPITAL MANAGEMENT, LLC	$182.0K	49,593
VANGUARD CAPITAL MANAGEMENT LLC	$121.4K	33,091
UBS Group AG	$115.2K	31,398
VANGUARD FIDUCIARY TRUST CO	$50.3K	13,692
JANE STREET GROUP, LLC	$46.4K	12,634
NORTHERN TRUST CORP	$38.2K	10,402
PNC FINANCIAL SERVICES GROUP, INC.	$18.1K	4,943
Tower Research Capital LLC (TRC)	$5.0K	1,356
BlackRock, Inc.	$3.4K	913
OSAIC HOLDINGS, INC.	$714.00	195

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ICU on your watchlist

Track score changes the day SeaStar Medical Holding Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ICU a good stock to buy?

13F Pro's AI-powered analysis of SeaStar Medical Holding Corp (ICU) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ICU are available on the ICU stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ICU is classified as a small company.

Which hedge funds own ICU?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ICU. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of SeaStar Medical Holding Corp's investment landscape.